NOVOCURE LTD. overview

NVCR Investors Have Opportunity to Lead NovoCure Limited Securities Fraud Lawsuit PR Newswire BENSALEM, Pa., Aug. 17, 2023 BENSALEM, Pa. , Aug. 17, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR ). Class Period: January 5, 2023 – June 5, 2023 Lead Plaintiff Deadline: August 18, 2023 Investors suffering...

The Law Offices of Frank R. Cruz reminds investors of the upcoming August 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired NovoCure Limited (“NovoCure” or the “Company”) (NASDAQ: NVCR ) securities between January 5, 2023 and June 5, 2023 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On June 6, 2023, NovoCure announced “positive results” from the clinical...

NVCR LAWSUIT ALERT: Levi & Korsinsky Notifies NovoCure Limited Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Aug. 17, 2023 NEW YORK , Aug. 17, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of NovoCure investors who were adversely affected by alleged securities fraud between January...

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against NovoCure Limited (“NovoCure” or the “Company”) (NASDAQQ: NVCR) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired NovoCure securities between January 5, 2023 and June 5, 2023, both dates inclusive (the “Class Period”). Investors have until...

NVCR IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR PR Newswire NEW YORK, Aug. 16, 2023 NEW YORK , Aug. 16, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NovoCure Limited (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023 , both dates inclusive (the "Class Period"), of the important...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NovoCure Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 18, 2023 - (NASDAQ: NVCR) PR Newswire NEW YORK, Aug. 16, 2023 NEW YORK , Aug. 16, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NovoCure Limited. Shareholders who purchased shares of NVCR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment...

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against NovoCure Limited (NasdaqGS: NVCR), if they purchased the Company’s securities between January 5, 2023 to June 5, 2023, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New...

LOS ANGELES, CA / ACCESSWIRE / August 15, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against NovoCure Limited ("NovoCure" or "the Company") (NASDAQ:NVCR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 5, 2023 and June 5, 2023, inclusive (the...